FDA Inspection
Eli Lilly and CompanyEli Lilly and Company – FDA Inspection, Sep 11, 2025
Record Details
This FDA Inspection record concerns Eli Lilly and Company, with an inspection on September 11, 2025, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · d715afa3-358a-4c9f-b4e4-13b0afa04843
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1282100
- FDA center
- Human Drugs
- Project area
- New Drug Evaluation
FDA Citations
2- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.